SCHEMBL23327971

SCHEMBL23327971

Brc1ccc2oc3nc4ccccc4nc3c2c1

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CA9 Q16790 1/20 0.43
CSNK2B P67870 6/20 0.42
CSNK2A2 P19784 4/20 0.42
PIM1 P11309 6/20 0.41
PIM3 Q86V86 3/20 0.41
PIM2 Q9P1W9 3/20 0.41
CDC7 O00311 3/20 0.41
CSNK2A1 P68400 3/20 0.41
CSNK2A3 Q8NEV1 1/20 0.41
NQO2 P16083 3/20 0.41
GABRP O00591 2/20 0.41
GABRD O14764 2/20 0.41
GABRA1 P14867 2/20 0.41
GABRB1 P18505 2/20 0.41
GABRG2 P18507 2/20 0.41
GABRB3 P28472 2/20 0.41
GABRA5 P31644 2/20 0.41
GABRA3 P34903 2/20 0.41
GABRA2 P47869 2/20 0.41
GABRB2 P47870 2/20 0.41

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL23353229 0.82 NQO2 (0.41) CA9CSNK2BCSNK2A2NQO2MAPT
SCHEMBL31683842 0.82 NQO2 (0.41) CA9CSNK2BCSNK2A2NQO2MAPT
SCHEMBL26819813 0.81 GABRP (0.49) CA9CSNK2BCSNK2A2PIM1PIM3
SCHEMBL19876402 0.81 KMT2A (0.47) CSNK2BCSNK2A2PIM1PIM3PIM2
SCHEMBL13907551 0.81 KMT2A (0.47) NQO2GABRPGABRDGABRA1GABRB1
SCHEMBL20967544 0.79 GAA (0.46) CSNK2BCSNK2A2PIM1PIM3PIM2
SCHEMBL17690425 0.79 IDO1 (0.43) CA9CSNK2BCSNK2A2PIM1GABRP
SCHEMBL22273595 0.79 MEN1 (0.42) PIM1PIM3CSNK2A1NQO2MAPT
SCHEMBL24066629 0.78 MEN1 (0.41) CA9PIM1PIM3CSNK2A1NQO2
SCHEMBL23352845 0.75 L3MBTL1 (0.42) CSNK2BCSNK2A2PIM1PIM3PIM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-12415949-B2 Compound, organic electroluminescent device, and display device SK INC. (KR) 2025-09-16 US disclosed
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE SK MATERIALS CO., LTD. (KR) 2021-05-13 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-12415949-B2 Compound, organic electroluminescent device, and display device L1CAM, EML4, OCIAD2 CA9 1797/4885CSNK2B 4836/4885CSNK2A2 4843/4885
US-20210143337-A1 COMPOUND, ORGANIC ELECTROLUMINESCENT DEVICE, AND DISPLAY DEVICE L1CAM, EML4, OCIAD2 CA9 1797/4885CSNK2B 4836/4885CSNK2A2 4843/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.